Literature DB >> 26335933

The Frequent Unusual Headache Syndromes: A Proposed Classification Based on Lifetime Prevalence.

Marcelo M Valença1,2, Daniella A de Oliveira1.   

Abstract

BACKGROUND: There is no agreement on a single cutoff point or prevalence for regarding a given disease as rare. The concept of what is a rare headache disorder is even less clear and the spectrum from a very frequent, frequent, occasional to rare headache syndrome is yet to be established.
OBJECTIVE: An attempt has been made to estimate the lifetime prevalence of each of the headache subtypes classified in the ICHD-II.
METHOD: Using the ICHD-II, 199 different headache subtypes were identified. The following classification was made according to the estimated lifetime prevalence of each headache disorder: very frequent (prevalence >10%); frequent (between 1 and 10%); occasional (between 0.07 and 1%); and unusual or rare (<0.07%).
RESULTS: One hundred and fifty-four of 199 (77%) were categorized as unusual headache disorders, 7/199 (4%) as very frequent, 9/199 (5%) as frequent, and 29/199 (15%) as occasional forms of headache disorder.
CONCLUSION: The unusual headache syndromes do not appear to be as infrequent in clinical practice as has been generally believed. About three-fourths of the classified headache disorders found in the ICHD-II can be considered as rare. This narrative review article may be regarded as an introduction to the concept of unusual headaches and a proposed classification of all headaches (at least those listed in the ICHD-II).
© 2015 American Headache Society.

Entities:  

Keywords:  classification; lifetime prevalence; orphan disease; rare disease; unusual headache

Mesh:

Year:  2015        PMID: 26335933     DOI: 10.1111/head.12646

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  1 in total

1.  Commentary: Acute Tension-Type Headaches Are Associated with Impaired Cognitive Function and More Negative Mood.

Authors:  Marcelo M Valença
Journal:  Front Neurol       Date:  2016-06-30       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.